Authors:
McGaha, T
Saito, S
Phelps, RG
Gordon, R
Noben-Trauth, N
Paul, WE
Bona, C
Citation: T. Mcgaha et al., Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes, J INVES DER, 116(1), 2001, pp. 136-143
Authors:
Zhu, JF
Guo, LY
Watson, CJ
Hu-Li, J
Paul, WE
Citation: Jf. Zhu et al., Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion, J IMMUNOL, 166(12), 2001, pp. 7276-7281
Authors:
Ben-Sasson, SZ
Gerstel, R
Hu-Li, J
Paul, WE
Citation: Sz. Ben-sasson et al., Cell division is not a "clock" measuring acquisition of competence to produce IFN-gamma or IL-4, J IMMUNOL, 166(1), 2001, pp. 112-120
Authors:
Terabe, M
Matsui, S
Noben-Trauth, N
Chen, HJ
Watson, C
Donaldson, DD
Carbone, DP
Paul, WE
Berzofsky, JA
Citation: M. Terabe et al., NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway, NAT IMMUNOL, 1(6), 2000, pp. 515-520
Authors:
Radu, DL
Noben-Trauth, N
Hu-Li, J
Paul, WE
Bona, CA
Citation: Dl. Radu et al., A targeted mutation in the IL-4R alpha gene protects mice against autoimmune diabetes, P NAS US, 97(23), 2000, pp. 12700-12704
Citation: N. Noben-trauth et al., Conventional, naive CD4(+) T cells provide an initial source of IL-4 during Th2 differentiation, J IMMUNOL, 165(7), 2000, pp. 3620-3625
Authors:
Jankovic, D
Kullberg, MC
Noben-Trauth, N
Caspar, P
Paul, WE
Sher, A
Citation: D. Jankovic et al., Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4(+) lymphocytes with a Th2 cytokine profile, J IMMUNOL, 164(6), 2000, pp. 3047-3055
Citation: H. Huang et We. Paul, Protein tyrosine phosphatase activity is required for IL-4 induction of IL-4 receptor alpha-chain, J IMMUNOL, 164(3), 2000, pp. 1211-1215
Authors:
Ben-Sasson, SZ
Makedonski, K
Hu-Li, J
Paul, WE
Citation: Sz. Ben-sasson et al., Survival and cytokine polarization of naive CD4(+) T cells in vitro is largely dependent on exogenous cytokines, EUR J IMMUN, 30(5), 2000, pp. 1308-1317
Authors:
Grossman, Z
Polis, M
Feinberg, MB
Grossman, Z
Levi, I
Jankelevich, S
Yarchoan, R
Boon, J
de Wolf, F
Lange, JMA
Goudsmit, J
Dimitrov, DS
Paul, WE
Citation: Z. Grossman et al., Ongoing HIV dissemination during HAART, NAT MED, 5(10), 1999, pp. 1099-1104
Authors:
Nelms, K
O'Neill, TJ
Li, SQ
Hubbard, SR
Gustafson, TA
Paul, WE
Citation: K. Nelms et al., Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain, MAMM GENOME, 10(12), 1999, pp. 1160-1167
Citation: C. Pannetier et al., Bias in the expression of IL-4 alleles: The use of T cells from a GFP knock-in mouse, COLD S HARB, 64, 1999, pp. 599-602
Authors:
Yoshimoto, T
Tsutsui, H
Tominaga, K
Hoshino, K
Okamura, H
Akira, S
Paul, WE
Nakanishi, K
Citation: T. Yoshimoto et al., IL-18, although antiallergic when administered with IL-12, stimulates IL-4and histamine release by basophils, P NAS US, 96(24), 1999, pp. 13962-13966
Authors:
Dent, AL
Doherty, TM
Paul, WE
Sher, A
Staudt, LM
Citation: Al. Dent et al., BCL-6-deficient mice reveal an IL-4-independent, STAT-6-dependent pathway that controls susceptibility to infection by Leishmania major, J IMMUNOL, 163(4), 1999, pp. 2098-2103
Authors:
Jankovic, D
Kullberg, MC
Noben-Trauth, N
Caspar, P
Ward, JM
Cheever, AW
Paul, WE
Sher, A
Citation: D. Jankovic et al., Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile, J IMMUNOL, 163(1), 1999, pp. 337-342